CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 272 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05064384
NCT05064384N/ACompleted
CompareCT.gov

Axonics SacRal NeuromodulaTIon System RegisTRY Study : ARTISTRY

Axonics, Inc.·observational·Posted Oct 1, 2021·Updated Sep 22, 2025

In Brief

An observational study for Urinary Retention and 3 related conditions. Completed, enrolled 272 participants across 27 sites in 2 countries.

Detailed Summary

To assess the post-market clinical outcomes with use of the Axonics Sacral Neuromodulation System(s).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Retention, Urinary Urge Incontinence, Urgency-Frequency, Fecal Incontinence
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 1, 2021
Enrollment StartNov 30, 2020
Primary CompletionOct 6, 2023
Study CompletionMar 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.8 years ago